Effects of passage number on growth and productivity of hybridoma secreting MRSA anti-PBP2a monoclonal antibodies
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/32243 |
Resumo: | Universidade Federal Fluminense. Laboratório de Tecnologia de Produtos Naturai. Niterói, RJ, Brasil. |
id |
CRUZ_078273d8f1e939b30806aff5dac9dd0e |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/32243 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Corrêa, Arthur LuizSenna, José Procópio MorenoSousa, Álvaro Paiva Braga de2019-03-27T13:24:33Z2019-03-27T13:24:33Z2016CORRÊA, Arthur Luiz; SENNA, José Procópio Moreno; SOUSA, Álvaro Paiva Braga de. Effects of passage number on growth and productivity of hybridoma secreting MRSA anti-PBP2a monoclonal antibodies. Cytotechnology, Dordrecht, v. 68, n. 3, p.419-427, 2016.1573-0778https://www.arca.fiocruz.br/handle/icict/3224310.1007/s10616-014-9794-0engEffects of passage number on growth and productivity of hybridoma secreting MRSA anti-PBP2a monoclonal antibodiesinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleUniversidade Federal Fluminense. Laboratório de Tecnologia de Produtos Naturai. Niterói, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Fundação Oswaldo Cruz. Instituto de Tecnologia em Imunobiológicos. Rio de Janeiro, RJ, Brasil.Monoclonal antibodies (mAb) are high added value glycoproteins recommended for immunotherapy, diagnosis, and also for the treatment of bacterial infections resistant to multiple drugs such as Methicillin Resistant Staphylococcus aureus (MRSA). In addition to environmental conditions related to cell cultures, the intrinsic characteristics of hybridoma cells, like the secretion stability of monoclonal antibodies by the cells through successive subcultures, are relevant for the characterization of cell lines related to the productivity of mAb. The rate of mAb production differs significantly between different cell lines and different passage numbers, and it is an important variable in characterization of cell lines. In order to find a more robust, faster-growing, and higher-productivity cell line of hybridoma, cultivations in 24-well plates were performed in different subculture periods, or cell passages (P), of hybridoma cells producing MRSA anti-PBP2a monoclonal antibodies [MRSA-antiPBP2a (mAb)]. The objective of this study was to study the effects of cell growth and production of MRSA-antiPBP2a mAb secreted by murine hybridoma cells grown in different passages as well as determine the which passages the hybridomas can be cultivated without harming their growth and productivity. So, cell growth profiles of hybridomas secreting MRSA-antiPBP2a (mAb) and the production of MRSA-antiPBP2a mAb in different subculture periods or cell passages (P) were studied. Cell growth tests, monoclonal antibody productivity, and metabolite characteristics revealed substantial differences in those cells kept between P10 and P50. Similarities in the secretion of monoclonal antibody, growth, and metabolic profiles, were noted in the MRSA-antiPBP2a mAb producing hybridoma cells kept between P10 and P20. Also, glucose consumption (g/L) and lactate production (g/L) in the latter cell cultures were monitored daily through biochemical analyzer. As of P30, it was observed a 4.4 times reduction in productivity, a 13 % reduction in metabolic yield, and a significant change in cell growth. Secretion of MRSA-antiPBP2a mAb should be obtained through the culture of hybridomas up to P20 in order to keep its stability.Antibody anti-PBP2aHybridomaMethicilinStaphylococcus aureusinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txttext/plain1748https://www.arca.fiocruz.br/bitstream/icict/32243/1/license.txt8a4605be74aa9ea9d79846c1fba20a33MD51ORIGINALF115-10616_2014_Article_9794.pdfapplication/pdf1313223https://www.arca.fiocruz.br/bitstream/icict/32243/2/F115-10616_2014_Article_9794.pdf9b92e60c8bfe1ff7c844719c932c4d62MD52TEXTF115-10616_2014_Article_9794.pdf.txtF115-10616_2014_Article_9794.pdf.txtExtracted texttext/plain29743https://www.arca.fiocruz.br/bitstream/icict/32243/3/F115-10616_2014_Article_9794.pdf.txt37a34b004cc7a649c6c9a55e3b42fbf5MD53icict/322432019-04-04 02:03:18.447oai:www.arca.fiocruz.br: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Repositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352019-04-04T05:03:18Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Effects of passage number on growth and productivity of hybridoma secreting MRSA anti-PBP2a monoclonal antibodies |
title |
Effects of passage number on growth and productivity of hybridoma secreting MRSA anti-PBP2a monoclonal antibodies |
spellingShingle |
Effects of passage number on growth and productivity of hybridoma secreting MRSA anti-PBP2a monoclonal antibodies Corrêa, Arthur Luiz Antibody anti-PBP2a Hybridoma Methicilin Staphylococcus aureus |
title_short |
Effects of passage number on growth and productivity of hybridoma secreting MRSA anti-PBP2a monoclonal antibodies |
title_full |
Effects of passage number on growth and productivity of hybridoma secreting MRSA anti-PBP2a monoclonal antibodies |
title_fullStr |
Effects of passage number on growth and productivity of hybridoma secreting MRSA anti-PBP2a monoclonal antibodies |
title_full_unstemmed |
Effects of passage number on growth and productivity of hybridoma secreting MRSA anti-PBP2a monoclonal antibodies |
title_sort |
Effects of passage number on growth and productivity of hybridoma secreting MRSA anti-PBP2a monoclonal antibodies |
author |
Corrêa, Arthur Luiz |
author_facet |
Corrêa, Arthur Luiz Senna, José Procópio Moreno Sousa, Álvaro Paiva Braga de |
author_role |
author |
author2 |
Senna, José Procópio Moreno Sousa, Álvaro Paiva Braga de |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Corrêa, Arthur Luiz Senna, José Procópio Moreno Sousa, Álvaro Paiva Braga de |
dc.subject.en.pt_BR.fl_str_mv |
Antibody anti-PBP2a Hybridoma Methicilin Staphylococcus aureus |
topic |
Antibody anti-PBP2a Hybridoma Methicilin Staphylococcus aureus |
description |
Universidade Federal Fluminense. Laboratório de Tecnologia de Produtos Naturai. Niterói, RJ, Brasil. |
publishDate |
2016 |
dc.date.issued.fl_str_mv |
2016 |
dc.date.accessioned.fl_str_mv |
2019-03-27T13:24:33Z |
dc.date.available.fl_str_mv |
2019-03-27T13:24:33Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
CORRÊA, Arthur Luiz; SENNA, José Procópio Moreno; SOUSA, Álvaro Paiva Braga de. Effects of passage number on growth and productivity of hybridoma secreting MRSA anti-PBP2a monoclonal antibodies. Cytotechnology, Dordrecht, v. 68, n. 3, p.419-427, 2016. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/32243 |
dc.identifier.issn.pt_BR.fl_str_mv |
1573-0778 |
dc.identifier.doi.none.fl_str_mv |
10.1007/s10616-014-9794-0 |
identifier_str_mv |
CORRÊA, Arthur Luiz; SENNA, José Procópio Moreno; SOUSA, Álvaro Paiva Braga de. Effects of passage number on growth and productivity of hybridoma secreting MRSA anti-PBP2a monoclonal antibodies. Cytotechnology, Dordrecht, v. 68, n. 3, p.419-427, 2016. 1573-0778 10.1007/s10616-014-9794-0 |
url |
https://www.arca.fiocruz.br/handle/icict/32243 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/32243/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/32243/2/F115-10616_2014_Article_9794.pdf https://www.arca.fiocruz.br/bitstream/icict/32243/3/F115-10616_2014_Article_9794.pdf.txt |
bitstream.checksum.fl_str_mv |
8a4605be74aa9ea9d79846c1fba20a33 9b92e60c8bfe1ff7c844719c932c4d62 37a34b004cc7a649c6c9a55e3b42fbf5 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813009063088226304 |